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Abstract
Background: Previous studies of mixed background mice have demonstrated that targeted deletion of
Vgf produces a lean, hypermetabolic mouse that is resistant to diet-, lesion-, and genetically-induced
obesity. To investigate potential mechanism(s) and site(s) of action of VGF, a neuronal and endocrine
secreted protein and neuropeptide precursor, we further analyzed the metabolic phenotypes of two
independent VGF knockout lines on C57Bl6 backgrounds.
Results: Unlike hyperactive VGF knockout mice on a mixed C57Bl6-129/SvJ background, homozygous
mutant mice on a C57Bl6 background were hypermetabolic with similar locomotor activity levels to Vgf+/
Vgf+  mice, during day and night cycles, indicating that mechanism(s) other than hyperactivity were
responsible for their increased energy expenditure. In Vgf-/Vgf- knockout mice, morphological analysis of
brown and white adipose tissues (BAT and WAT) indicated decreased fat storage in both tissues, and
decreased adipocyte perimeter and area in WAT. Changes in gene expression measured by real-time RT-
PCR were consistent with increased fatty acid oxidation and uptake in BAT, and increased lipolysis,
decreased lipogenesis, and brown adipocyte differentiation in WAT, suggesting that increased sympathetic
nervous system activity in Vgf-/Vgf- mice may be associated with or responsible for alterations in energy
expenditure and fat storage. In addition, uncoupling protein 1 (UCP1) and UCP2 protein levels,
mitochondrial number, and mitochondrial cristae density were upregulated in Vgf-/Vgf-  BAT. Using
immunohistochemical and histochemical techniques, we detected VGF in nerve fibers innervating BAT and
Vgf  promoter-driven reporter expression in cervical and thoracic spinal ganglia that project to and
innervate the chest wall and tissues including BAT. Moreover, VGF peptide levels were quantified by
radioimmunoassay in BAT, and were found to be down-regulated by a high fat diet. Lastly, despite being
hypermetabolic, VGF knockout mice were cold intolerant.
Conclusion:  We propose that VGF and/or VGF-derived peptides modulate sympathetic outflow
pathways to regulate fat storage and energy expenditure.
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Background
The sympathetic nervous system (SNS) plays an impor-
tant role in the regulation of glucose and fat metabolism,
and its dysfunction could predispose to obesity and type
2 diabetes mellitus. Mice with defective signaling in the
melanocortin pathway, including those that fail to express
the hypothalamic melanocortin 4 receptor (MC4R) or its
agonist alpha-melanocyte stimulating hormone (-
MSH), and those that over-express the MC4R antagonists
agouti or agouti-related protein (AGRP or ART), all
develop late onset obesity and insulin resistance [1]. The
MC4R is expressed in the hypothalamic paraventricular
nucleus (PVN), which contains neurons that innervate
parasympathetic and sympathetic preganglionic cells in
the brainstem and spinal cord, and throughout the brain
in sympathetic circuits that innervate brown adipose tis-
sue (BAT) [2,3]. These projections give the hypothalamus
direct input to the autonomic nervous system, controlling
glucose and energy homeostasis [4,5]. The central
melanocortin system has therefore been proposed to
modulate autonomic outflow and food intake [6,7]
through its effects on sympathetic activity to inhibit pan-
creatic insulin secretion and increase energy utilization
[8,9].
Brown and white adipose tissues (BAT and WAT) are sites
where humoral factors (e.g. leptin and adiponectin) are
synthesized and afferent nerve signals generated, which
together convey the state of energy storage to the hypoth-
alamus. These signals contribute to the adaptive responses
that occur following changes in the environment, includ-
ing diet and cold. BAT is the primary site of thermogenesis
in rodents and newborn humans, is richly innervated by
the SNS, and adipocytes are densely packed with mito-
chondria that contribute to energy generation and heat
dissipation. The thermogenic capacity of BAT is primarily
due to uncoupling protein 1 (UCP1) on the inner mito-
chondrial membrane that uncouples the respiratory chain
from ATP generation, producing heat [10]. Norepineprine
(NE), released from sympathetic nerve endings, stimu-
lates lipolysis in WAT and increases UCP1 gene expression
in BAT; these responses to a high fat diet or cold exposure
are controlled at least in part by the central melanocortin
system [3,11]. Increased UCP1 expression in WAT, the
result of SNS stimulation or genetic background, is associ-
ated with brown adipocyte induction in WAT depots, and
leads to reversal of diet-induced and genetic obesity [12-
16]. Taken together, these data argue for an important role
of the SNS in the control of energy expenditure via out-
flow to both white and brown adipose tissues.
We have previously reported suppression of obesity,
hyperinsulinemia and hyperglycemia in Ay/a agouti and
melanocortin 4 receptor deficient (MC4R-/MC4R-) mice
by targeted deletion of the Vgf  gene [17,18]. VGF is a
secreted protein and peptide precursor that is expressed
throughout the brain, in neurons, and in several neuroen-
docrine and endocrine tissues [19,20]. Mice with a tar-
geted deletion of Vgf are lean and hypermetabolic, and
resist developing obesity and diabetes [21]. Neonatal
treatment of Vgf-/Vgf- mice with monosodium glutamate,
which damages the hypothalamus and the hypothalamic
projections to the autonomic nervous system [22-24],
blocks the development of the lean phenotype [17,18].
This suggests that VGF could regulate energy balance by
reducing sympathetic outflow pathway activity to periph-
eral tissues. To gain insight into the molecular and cellular
changes that may be responsible for the increase in energy
expenditure and decrease in adipose stores detected in
VGF knockout mice, we examined the effect that targeted
ablation of VGF has on the regulation of gene expression
in adipose tissues, analyzing two independent VGF
knockout mouse lines on C57Bl6 backgrounds. We noted
alterations in the expression of genes encoding enzymes
that control fat synthesis and breakdown, consistent with
increased SNS activity. We further found that VGF was
expressed in neural pathways innervating BAT, quantified
VGF-derived peptides in BAT by RIA, and demonstrated
increased UCP1 and UCP2 levels in VGF knockout BAT
that were associated with alterations in mitochondrial
number and morphology. Our studies support the
hypothesis that VGF modulates sympathetic outflow
pathway activity to control fat storage and energy expend-
iture.
Results
Metabolic rates are higher, fat and lean body mass lower, 
and activity levels similar in Vgf-/Vgf- compared to Vgf+/
Vgf+ mice on a C57Bl6 background
Previous studies of VGF knockout mice on a mixed
C57Bl6-129/SvJ background (designated VGFMixed knock-
out and abbreviated VGFM knockout or VgfM -/-) indicated
that mice with the Vgf gene ablated were hyperactive and
hypermetabolic. To investigate whether background
strain had an effect on metabolic phenotype, we analyzed
the same line of VGF knockout mice that had been back-
crossed   10 generations to obtain a homogeneous
C57Bl6 background (designated VGFC57  knockout or
VgfC57 -/-), as well as the F3 generation of an independent
mouse line, generated by Regeneron Pharmaceuticals Inc.
using F1H4 ES cells (a 129B6/F1-derived cell line), also
primarily on a C57Bl6 background (>83% C57Bl6 back-
ground; designated VGFR knockout or VgfR -/-) [25]. Simi-
lar results were obtained using both of these VGF mutant
mouse lines on C57Bl6 backgrounds. As shown in Figure
1, metabolic rates remained high in homozygous VGFR
knockout mice, with basal metabolic rate (BMR), defined
as oxygen consumption (V02) during the light rest period,
significantly elevated (p < 0.001; two tailed t-test) in VGF
null compared to wild-type littermates. Locomotor activ-BMC Physiology 2009, 9:19 http://www.biomedcentral.com/1472-6793/9/19
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ity levels and food intake were indistinguishable between
control mice and either VGFR (Figure 1) or VGFC57 (data
not shown) knockout mice. Body weight and length were
reduced in VGFR and VGFC57 knockout mice [Figure 2 and
[18], respectively], and body mass analysis indicated a
reduction in fat and lean mass (Figure 2A-C). Consistent
with reduced fat and lean mass, low leptin levels, and the
hypothesized increase in sympathetic tone in VGF mutant
mice, significant reductions in both bone density and
bone mineralization were also noted in VGFR knockout
mice (Figure 2E-F). Serum chemistries revealed significant
reductions in HDL, triglyceride, albumin, and leptin in
VGFR knockout mice, while total cholesterol, total pro-
tein, insulin, LDL, creatinine, magnesium, urea, and uric
acid were not significantly different between knockout
and wild type mice on the C57Bl6 background (Table 1).
Morphological changes in BAT and WAT of homozygous 
VGF mutant mice suggest an increase in lipolysis and FA 
oxidation
Histological examinations of adipose tissues in Vgf -/- and
wild type mice were performed to gain insight into which
tissues may be responsible for increased energy expendi-
ture and/or decreased fat stores. We compared tissues
from VgfR -/-, -/+, and +/+ mice, although previous studies
have not demonstrated significant metabolic differences
between wild type and heterozygous VGF knockout mice
[17,18,21]. Because fat mass is significantly reduced in
VgfC57 and VgfR -/- mice (e.g. Figure 2), certain fat depots
were extremely difficult to identify and quantify on the
C57Bl6 background, including visceral mesenteric fat,
subcutaneous abdominal fat, and retroperitoneal fat.
Even though these various fat depots are differentially
responsive to a number of stimuli (e.g. diet), and are
thought to make specific contributions to glucose and
metabolic homeostasis [26], we chose to focus on epidi-
dymal WAT and interscapular BAT pads for histological
and gene expression analyses because they could be repro-
ducibly isolated from knockout mice. BAT and WAT have
distinct physiological roles in maintaining energy home-
ostasis; BAT is the most highly metabolic and innervated
tissue in rodents, while WAT is the principal site of adi-
pose storage. The BAT of VgfC57 -/-, VgfR -/-, VgfR +/-, and
wild type mice was comprised of typical multilocular
cells, however, these cells in VGF knockout mice con-
tained large numbers of smaller lipid droplets, suggesting
that the tissue remained metabolically active (Figure 3D-
F; quantification panel G; Additional file 1: Supplemental
Figure 1). Moreover, the WAT depot that normally sur-
rounds BAT in wild type mice was absent in Vgf -/- mice
(see Additional files 1 and 2: Supplemental Figures 1 and
2). WAT from Vgf -/- mice contained less stored lipid in
comparison to wild type mice (Figure 3, C and 3A), con-
sistent with the body composition fat mass analysis (Fig-
ure 2). Morphometric analysis indicated that mean
adipocyte area was significantly reduced in knockout WAT
(Figure 3H), which was associated with a shift in the dis-
tribution of adipocytes favoring those with smaller perim-
eters (Figure 3I). In general, quantitative analysis of WAT
and BAT demonstrated that heterozygous VGFR knockout
mice had an intermediate phenotype between wild type
and homozygous knockout mice (Figure 3G and 3H).
Overall, H&E analysis of VgfC57 -/- BAT and WAT (Addi-
tional file 1: Supplemental Figure 1) revealed a similar
pattern of histological staining to that obtained with the
respective VgfR -/- tissues (Figure 3).
Vgf-/Vgf- mice have altered adipose mRNA levels encoding 
proteins involved in the regulation of energy storage, fatty 
acid utilization, and sympathetic nervous system activity
The adipose tissues of VGFC57 and VGFR mutant mice were
morphologically different from wild type mice. To under-
stand the molecular mechanisms responsible for
decreased fat stores in epididymal WAT and interscapular
BAT, we carried out an extensive analysis of gene expres-
sion in these VGFC57 tissues using real-time RT-PCR. In
WAT, the levels of mRNAs, encoding enzymes responsible
for building fat stores, acetyl coA carboxylase (ACC), glyc-
erol-3-phosphate acyltransferse (GPAT) and diacylglyc-
erol acyltransferase (DGAT), were unaltered in Vgf -/-
mice, while an increase in mRNA levels encoding hor-
mone sensitive lipase (HSL), an enzyme responsible for
lipolysis which mobilizes fat, was found in Vgf -/- mice.
Gene expression of peroxisome-proliferator activated
receptor gamma (PPAR), a protein that promotes adi-
pocyte differentiation, and sterol regulatory element bind-
ing protein 1C (SREBP-C1), which activates genes
responsible for lipogenesis and glucose utilization [27],
were decreased in VGF knockout WAT. RNA levels encod-
ing fatty acid synthase (FAS), an enzyme that synthesizes
Table 1: Serum measures in wild type (VgfR +/+) and VGF 
knockout (VgfR -/-) mice.
VgfR +/+ VgfR -/- P value
Insulin (ng/mL) 0.82 ± 0.14 0.67 ± 0.19 0.55
Leptin (pg/mL) 2351 ± 546 399 ± 80 0.003*
Albumin (g/dL) 3.02 ± 0.07 2.74 ± 0.04 0.01*
Total Protein (g/dL) 5.24 ± 0.12 4.98 ± 0.09 0.10
Creatinine (mg/dL) 0.43 ± 0.02 0.39 ± 0.01 0.09
Magnesium (mg/dL) 2.43 ± 0.08 2.33 ± 0.07 0.35
Triglyceride (mg/dL) 80.29 ± 9.31 46.03 ± 3.24 0.003*
Urea (mg/dL) 20.94 ± 0.99 20.45 ± 0.62 0.68
Uric Acid (mg/dL) 1.41 ± 0.14 1.50 ± 0.17 0.69
Cholesterol (mg/dL) 90.25 ± 5.86 76.18 ± 3.37 0.06
LDL (mg/dL) 4.36 ± 0.57 5.21 ± 0.57 0.31
HDL (mg/dL) 53.33 ± 4.80 40.20 ± 2.05 0.02*
Chemistry analyses were carried out on serum samples as previously 
described [103]. Data are expressed as mean ± SEM; n = 8 for each 
genotype. P values of less than 0.05 were considered significant and 
are denoted by the *.BMC Physiology 2009, 9:19 http://www.biomedcentral.com/1472-6793/9/19
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VGF-deficient mice on a C57Bl6 background are hypermetabolic, with normal food intake and locomotor activity Figure 1
VGF-deficient mice on a C57Bl6 background are hypermetabolic, with normal food intake and locomotor 
activity. Metabolic cage analysis revealed that VgfR -/- mice have significantly increased O2 (V02, panel A) and CO2 (VCO2, panel 
B) consumption (two-tailed t-test; p  0.05), while respiratory quotient (panel C), food intake (panels D and E) and locomotor 
activity (panel F) were similar to wild type littermates (n = 7-8 mice of each genotype). Alternating white and grey shaded 
regions in panels E-F represent light rest and dark active periods, respectively.BMC Physiology 2009, 9:19 http://www.biomedcentral.com/1472-6793/9/19
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fatty acids from acetyl COA and malonyl COA, however,
was elevated in Vgf -/- WAT. In VGF knockout BAT, levels
of mRNAs encoding the lipogenic proteins ACC, GPAT
and PPAR were increased (Table 2).
Next we looked at gene products responsible for fatty acid
beta-oxidation in these tissues. RNA levels of proteins
responsible for fatty acid and glucose uptake, lipoprotein
lipase (LPL) and glucose 4 transporter (GLUT 4), and
translocation of fatty acids to the mitochondria, carnitine
palmitoyltransferase 1 (CPT1), were up regulated in Vgf -
/- BAT, whereas LPL and GLUT4 gene expression were
down regulated and CPT1 mRNA levels unaltered in WAT.
PPAR is thought to play an important role in lipid
metabolism, and mRNA levels were increased in VGF
knockout BAT and WAT. Furthermore, mRNA levels
encoding PPAR coactivator 1 (PGC-1), a co-activator of
nuclear receptors that increases metabolism by stimulat-
ing mitochondrial biogenesis and respiration, were up-
regulated in BAT and WAT of the VgfC57 -/- mutant mouse,
and a concomitant increase in cytochrome C oxidase II
(COX II) mRNA levels was also found (Table 3).
We then investigated whether altered BAT morphology
could be associated with an increase in thermogenesis by
examining mRNA levels for the uncoupling proteins.
VGF-deficient mice on a C57Bl6 background have decreased fat and lean body mass, and decreased bone mineral density and  content Figure 2
VGF-deficient mice on a C57Bl6 background have decreased fat and lean body mass, and decreased bone min-
eral density and content. Body weight (Panel A) (grams), body composition (Panels B and C) [lean mass (LM) and fat mass 
(FM)] (grams), length (Panel D) (cm), bone mineral density (BMD) (Panel E) (g/cm2) and bone mineral content (BMC) (Panel F) 
(grams), were determined in VGFR mice using dual emission x-ray absorption. Data are expressed as mean ± SEM (n = 7-8 male 
mice of each genotype per group).
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Lipid deposition in multilocular cells of brown adipose tissue (BAT) and unilocular cells of white adipose tissue (WAT) is  reduced in VGF knockout mice Figure 3
Lipid deposition in multilocular cells of brown adipose tissue (BAT) and unilocular cells of white adipose tissue 
(WAT) is reduced in VGF knockout mice. Representative sections of epididymal WAT (A-C) and interscapular BAT (D-
F) from ad lib-fed, age-matched VgfR +/+ (A, D), +/- (B, E) and -/- (C, F) were stained with H&E. Adipocytes in interscapular BAT 
and epididymal WAT from -/- mice (C and F) contain less lipid accumulation than the corresponding adipocytes from wild type 
mice (A and D). Scale bars are 50 m in length. Morphometric analysis of adipose tissue from VgfR +/+, +/-, and -/- mice was 
carried out using MetaMorph, as detailed in Materials and Methods. Lipid area in BAT (panel G), cell area in WAT (panel H), 
and the distribution of adipocyte perimeters in WAT (panel I), were quantified for each genotype. Note the significant reduc-
tion in lipid area in both +/- and -/- BAT (ANOVA, F (2,15) = 73.5, p < 0.0001), significant reduction in adipocyte area in -/- 
WAT (ANOVA, F (2,15) = 7.6, p = 0.005), and shift in the distribution of cells favoring those with significantly smaller perime-
ters in -/- and +/- WAT (comparison of mean perimeters in m; ANOVA, F (2,1167) = 166, p < 0.0001), compared to wild 
type. Values are mean ± SEM, *p < 0.05, **p = 0.005, ***p < 0.0001 compared to wild type (ANOVA and Bonferroni's posthoc 
test).BMC Physiology 2009, 9:19 http://www.biomedcentral.com/1472-6793/9/19
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Uncoupling Protein 1 (UCP1) by disrupting the proton
gradient across the inner mitochondrial membrane is cru-
cial for non-shivering thermogenesis, leading to heat pro-
duction (reviewed in [28-30]). UCP2 and UCP3 also
regulate proton conductance, however they require activa-
tion by reactive oxygen species, and may protect against
oxidative damage (reviewed in [28-30]). In addition,
UCP3 may transport fatty acids, while UCP2 may attenu-
ate insulin secretion in pancreatic beta cells. In VGFC57
knockout mice compared to wild type mice, we noted that
mRNA levels of UCP1 were lower in BAT, but the mRNA
levels of UCP2 and UCP3 were increased (Table 4). Nota-
bly, in WAT, levels of UCP1 mRNA were robustly
increased in Vgf -/- mice (Table 4).
Lastly, we looked at genes indicative of sympathetic nerv-
ous system (SNS) activity. The SNS-mediated physiologi-
cal responses, FA oxidation and lipolysis, mostly rely on
release of norepinephrine from the post-ganglionic neu-
rons which binds to beta-3-adrenergic receptors (3AR)
on the adipocyte's cell surface, as well as to the other beta
receptors, 1AR and 2AR. Mice with decreased sympa-
thetic activity due to leptin deficiency have a ~300-fold
reduction in 3AR mRNA in comparison to lean animals
[31,32]. Therefore we looked at the mRNA levels of the
beta-adrenergic receptors to provide indirect support for
an increase in SNS tone in VGF mutant mice. In BAT,
3AR mRNAs were increased in VGF knockout mice in
comparison to wild type mice. In WAT, however, the gene
expression of 2AR was significantly higher in Vgf -/- mice
than Vgf +/+ mice, while 3AR mRNA levels were similar
(Table 5).
Table 2: Expression of genes in epididymal WAT and interscapular BAT that contribute to lipolysis or lipogenesis in VGF knockout 
and wild type mice.
Tissue Gene Mean Cycle Threshold (Ct) 
Value
Std. Error Fold Difference in mRNA Levels 
(2Ct)
P-
Value
RNA Levels in VGFC57
-/- vs +/+ mice
BAT ACC Vgf-/Vgf- 2.57
Vgf+/Vgf+ 1.52
.596
.205
2.1 NS
BAT DGAT Vgf-/Vgf- 3.45
Vgf+/Vgf+ 3.52
.210
.092
1.0 NS
BAT GPAT Vgf-/Vgf- 6.95
Vgf+/Vgf+ 8.12
.253
.127
2.3 .0060 Increased
BAT PPAR Vgf-/Vgf -.633
Vgf+/Vgf+ 1.73
.285
.239
2.1 .002 Increased
WAT ACC Vgf-/Vgf- 5.20
Vgf+/Vgf+ 3.39
.517
.333
3.5 .001 Decreased
WAT DGAT Vgf-/Vgf- 6.88
Vgf+/Vgf+ 7.88
.370
.525
2.0 NS
WAT GPAT Vgf-/Vgf- 7.83
Vgf+/Vgf+ 9.01
.458
1.13
2.2 NS
WAT PPAR Vgf-/Vgf- 4.75
Vgf+/Vgf+ 3.60
.315
.138
2.2 .010 Decreased
WAT FAS Vgf-/Vgf- 2.45
Vgf+/Vgf+ 4.80
.193
.227
5.1 .0098 Increased
WAT SREBP1C Vgf-/Vgf- 12.6
Vgf+/Vgf+ 8.99
.953
.560
12.1 .001 Decreased
WAT HSL Vgf-/Vgf- 7.79
Vgf+/Vgf+ 11.6
.405
1.10
14.0 .022 Increased
Real time RT-PCR analysis was carried out in quadruplicate as described in the Methods. The fold difference was calculated from the indicated 
mean cycle threshold (Ct) values, the amplification cycle when product can first be detected: lower Ct values correspond to greater abundance. Ct 
values were normalized to the expression of the housekeeping gene beta-actin (Ct), and fold difference in mRNA calculated as 2Ct, as detailed 
in Methods, with p  0.05 considered significant.BMC Physiology 2009, 9:19 http://www.biomedcentral.com/1472-6793/9/19
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Western and electron microscopic analyses indicate that 
UCP1 and UCP2 protein levels and mitochondrial number 
are upregulated in VGF knockout BAT
To determine the basis of the hypermetabolic state in VGF
knockout mice, given the somewhat surprising lack of an
increase in UCP1 mRNA levels in BAT (Table 4), we exam-
ined protein levels of UCPs in BAT by western analysis,
and quantified mitochondrial size and number, and cris-
tae density, by electron microscopy. UCP1 and UCP2 pro-
tein levels were significantly increased in BAT from VgfR -/
- knockout compared to wild type mice (Figure 4, panels
A and B; p < 0.05, ANOVA). To determine whether mito-
Table 3: Expression of genes in epididymal WAT and interscapular BAT that contribute to fatty acid oxidation in VGF knockout and 
wild type mice.
Tissue Gene Mean Cycle Threshold (Ct) Value Std.
Error
Fold Difference in mRNA Levels 
(2Ct)
P-Value RNA Levels in VGFC57
-/- vs +/+ mice
BAT PPAR Vgf-/Vgf- 5.23
Vgf+/Vgf+ 5.83
.433
.222
1.5 NS
BAT LPL Vgf-/Vgf- 2.33
Vgf+/Vgf+ 3.48
.259
.263
2.2 .021 Increased
BAT CPT-1 Vgf-/Vgf- 13.9
Vgf+/Vgf+ 15.3
.546
.312
2.6 .05 Increased
WAT PGC-1 Vgf-/Vgf- 10.1
Vgf+/Vgf+ 12.2
.431
.271
4.3 .0028 Increased
WAT COX II Vgf-/Vgf- 1.91
Vgf+/Vgf+ 2.67
.207
.048
1.7 .019 Increased
WAT PPAR Vgf-/Vgf- 11.9
Vgf+/Vgf+ 14.3
.494.
.112
5.3 .0069 Increased
WAT LPL Vgf-/Vgf- 4.09
Vgf+/Vgf+ 0.96
1.13
.111
2.0 .0232 Decreased
WAT CPT-1 Vgf-/Vgf- 16.3
Vgf+/Vgf+ 16.7
.543
.427
1.3 NS
Real time RT-PCR analysis was carried out in quadruplicate as described in the Methods. The fold difference was calculated from the indicated 
mean cycle threshold (Ct) values, the amplification cycle when product can first be detected: lower Ct values correspond to greater abundance. Ct 
values were normalized to the expression of the housekeeping gene beta-actin (Ct), and fold difference in mRNA calculated as 2Ct, as detailed 
in Methods, with p  0.05 considered significant.
Table 4: Expression of genes in epididymal WAT and interscapular BAT that contribute to thermogenesis in VGF knockout and wild 
type mice.
Tissue Gene Mean Cycle Threshold (Ct) Value Std.
Error
Fold Difference in mRNA Levels 
(2Ct)
P-Value RNA Levels in VGFC57
-/- vs +/+ mice
BAT UCP1 Vgf-/Vgf- 3.53
Vgf+/Vgf+ 1.22
.843
.272
4.9 .024 Decreased
BAT UCP2 Vgf-/Vgf- 1.88
Vgf+/Vgf+ 4.15
.259
.233
4.8 .0013 Increased
WAT UCP1 Vgf-/Vgf- 11.2
Vgf+/Vgf+ 14.4
.433
.527
9.2 .0031 Increased
WAT UCP2 Vgf-/Vgf- 3.02
Vgf+/Vgf+ 3.86
.535
.275
1.8 .025 Increased
Real time RT-PCR analysis was carried out in quadruplicate as described in the Methods. The fold difference was calculated from the indicated 
mean cycle threshold (Ct) values, the amplification cycle when product can first be detected: lower Ct values correspond to greater abundance. Ct 
values were normalized to the expression of the housekeeping gene beta-actin (Ct), and fold difference in mRNA calculated as 2Ct, as detailed 
in Methods, with p  0.05 considered significant.BMC Physiology 2009, 9:19 http://www.biomedcentral.com/1472-6793/9/19
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chondrial biogenesis could be affected by germline Vgf
ablation, knockout and wild type BAT was examined by
electron microscopy (Figure 4, panels C-E and F-H,
respectively). Mitochondrial number was increased (Fig-
ure 4I), mitochondrial area decreased (Figure 4J), and
cristae density increased (Figure 4K), in VGF -/- knockout
compared to +/+ wild type mice.
VGF immunoreactivity can be detected in BAT and VGF-
derived AQEE30 peptide levels are regulated by diet
BAT is a highly metabolic tissue that is innervated by
noradrenergic sympathetic fibers, which also contain
other neuropeptides such as NPY [33-37]. As previous
studies suggested that VGF ablation could potentially
impact sympathetic nervous system activity to peripheral
metabolic tissues such as fat, and for technical reasons
immunohistochemical visualization of VGF in WAT was
difficult, we investigated whether VGF was expressed in
nerve fibers that innervate BAT. We first quantified the
level of VGF-derived C-terminal peptides by subjecting
acid extracts of BAT to a sensitive radioimmunoassay
(RIA) that has been previously described [38]. This RIA
utilizes a polyclonal antibody specific for the VGF-derived
C-terminal peptide AQEE30 (VGF peptides are designated
by the four N-terminal amino acids and length), so detects
AQEE30 and the N-terminally extended peptides that
contain this sequence, TLQP62 and NAPP129 [38].
Immunoreactive AQEE30 was detected in BAT, and was
found to be downregulated when C57Bl6 mice were fed a
high fat diet for two weeks (Figure 5A). Parenchymal
nerve fibers make direct contact with adipocytes, activat-
ing them via beta-adrenergic receptors, or are associated
with finely branched vessels that penetrate the tissue but
do not make direct contacts with the adipocytes [39,40].
By immunofluorescence and immunohistochemistry,
anti-VGF staining was found in BAT to abut adipocytes
and was also seen in the periarterial plexus (Additional
file 3: Supplemental Figure 3, panels A, C, D), similar to
the distribution reported for anti-tyrosine hydroxylase
(Additional file 3: Supplemental Figure 3, panel B), which
binds the rate-limiting enzyme in catecholamine biosyn-
thesis and is a marker of catecholaminergic nerves and ter-
minals [37]. Consistent with finding VGF in nerve fibers
and terminals that innervate BAT, we were also able to
indirectly localize Vgf gene expression in spinal ganglia
and intercostal nerves of heterozygous knockout mice.
Intercostal nerves, which contain autonomic and sensory
fibers that innervate BAT [41] and additional structures
including the skin and musculature of the chest and abdo-
men, and the dorsal root ganglia, which give rise to the
somatic and sensory afferents in the intercostal nerve,
were found to express -galactosidase from the lacZ
reporter gene that was knocked into the mouse Vgf locus
in Vgf+/Vgf-lacZ mice (Figure 5, panels B-C). These initial
data suggest that VGF and/or VGF-derived peptides could
be released from neurons that innervate adipose tissues,
as is NPY [42-44], and that VGF AQEE30 peptide levels in
BAT are regulated by diet; additional studies will be
required to determine whether adipocytes synthesize
Table 5: Expression of genes in epididymal WAT and interscapular BAT that contribute to sympathetic nervous system activity in 
VGF knockout and wild type mice.
Tissue Gene Mean Cycle Threshold (Ct) Value Std.
Error
Fold Difference in mRNA Levels 
(2Ct)
P-Value RNA Levels in VGFC57
-/- vs +/+ mice
BAT 3AR Vgf-/Vgf- 2.55
Vgf+/Vgf+ 2.90
.456
.461
1.3 NS
BAT 2AR Vgf-/Vgf- 4.50
Vgf+/Vgf+ 7.54
.730
.204
8.0 .0029 Increased
BAT 1AR Vgf-/Vgf- 8.41
Vgf+/Vgf+ 8.13
.222
.193
1.2 NS
WAT 3AR Vgf-/Vgf- 2.35
Vgf+/Vgf+ 1.37
.750
.278
1.9 NS
WAT 2AR Vgf-/Vgf- 5.71
Vgf+/Vgf+ 7.21
.361
.192
2.8 .0104 Increased
WAT 1AR Vgf-/Vgf- 4.43
Vgf+/Vgf+ 5.45
.634
.143
2.0 NS
Real time RT-PCR analysis was carried out in quadruplicate as described in the Methods. The fold difference was calculated from the indicated 
mean cycle threshold (Ct) values, the amplification cycle when product can first be detected: lower Ct values correspond to greater abundance. Ct 
values were normalized to the expression of the housekeeping gene beta-actin (Ct), and fold difference in mRNA calculated as 2Ct, as detailed 
in Methods, with p  0.05 considered significant.BMC Physiology 2009, 9:19 http://www.biomedcentral.com/1472-6793/9/19
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VGF ablation affects UCP1 & UCP2 protein expression, mitochondrial morphology, and mitochondrial number in BAT Figure 4
VGF ablation affects UCP1 & UCP2 protein expression, mitochondrial morphology, and mitochondrial 
number in BAT. Representative western blots of UCP1, UCP2, and GAPDH protein levels in BAT from VgfR +/+, +/-, and -/- 
mice (panel A), and densitometric quantification by NIH image (panel B). Comparable results were found in at least three addi-
tional experiments. Ablation of VGF significantly increased UCP1 and UCP2 levels in BAT from VgfR -/- but not VgfR +/- mice 
compared to wild type +/+ mice [n = 5 mice per group, mean ± SEM, F (2,12) = 4.35 (UCP1), F (2,12) = 3.33 (UCP2), *p < 
0.05, ANOVA and Dunnett's posthoc test]. Representative electron microscope photomicrographs of BAT from VgfR -/- (pan-
els C-E) and +/+ mice (panels F-H) are shown. The part of the image that is boxed in red is shown at higher magnification in the 
panel to its immediate right. Scale bars are 5 m (panels C and F), 2.5 m (panels D and G), and 1.25 m (panels E and H). 
Note that mitochondria are smaller and more numerous in VgfR -/- in comparison to +/+ BAT (compare panels E and H), which 
is quantified in panels I and J. In panel K, the number of cristae per m2 of mitochondrial area was quantified in VgfR -/- and +/+ 
BAT. Values are mean ± SEM; ***p = 0.0002 (panel E), **p = 0.001 (panel F), ***p < 0.0001 (panel G) (Student's t-test).BMC Physiology 2009, 9:19 http://www.biomedcentral.com/1472-6793/9/19
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VGF, analogous to recent reports that they produce NPY
[45,46].
VGF knockout mice are extremely sensitive to acute cold 
stress
In rodents, the principal functions of BAT are to generate
heat during cold exposure so as to maintain body temper-
ature (cold-induced thermogenesis), and to dissipate
excess energy in response to dietary intake (diet-induced
thermogenesis). To determine whether VGF ablation
affected BAT function and thermogenesis, VgfC57 -/- and
VgfC57 +/+ mice were acutely exposed to the cold. In con-
trast to wild type mice that were able to maintain body
temperature, VGF knockout mice despite being hypermet-
abolic rapidly became hypothermic at 4°C (Figure 6).
Discussion
In this study, we investigated the effect that targeted abla-
tion of VGF has on peripheral adiposity, and the possible
mechanism(s) by which this neuronal, endocrine, and
neuroendocrine secreted polypeptide might regulate fat
storage and autonomic homeostasis. VGF mutant mice on
a C57Bl6 background are hypermetabolic and lean, with
reduced lean and fat mass, despite normal food consump-
tion and locomotor activity levels (Figures 1 and 2). These
current findings are consistent with previous studies of
VGF mutant mice on a mixed C57Bl6/sv129 background
[21]. Thus, serum chemistries, insulin-tolerance, glucose-
tolerance, metabolic measurements, and body composi-
tion are all very similar among VGF knockout mice on
mixed (designated VGFM), homogeneous C57Bl6 (desig-
nated VGFC57), or ~83% C57Bl6 backgrounds (designated
VGFR) [17,18] and this report], with the notable exception
that VGF knockout mice on a C57Bl6 background (VGFR
and VGFC57) are not hyperactive (Figure 1 and data not
shown), and thus locomotor activity cannot play a sub-
stantive role in their increased energy expenditure.
Could increased sympathetic tone or sensitivity to nore-
pinephrine be responsible for alterations in adipose mor-
phology and the expression of critical gene products?
Decreased lipid accumulation in WAT, smaller interscapu-
lar WAT depots that are associated with BAT, and regions
of fat accretion in BAT, are consistent with increased sym-
pathetic nervous system activity. In addition, changes in
gene expression in WAT and BAT correlate with these mor-
phological differences, as does body composition analy-
sis. Activation of the sympathetic nervous system
promotes catabolism by increasing glucose and fatty acid
uptake into BAT [47], and by increasing lipolysis in WAT.
Hormone sensitive lipase (HSL) is induced by sympa-
thetic activity [48], is up-regulated by fasting in most adi-
pose depots except subcutaneous fat [49-51], and both
HSL mRNA and protein levels in adipose tissue are
decreased in the obese insulin-resistant state [52]. Of
note, HSL was one of the most robustly up-regulated
genes in WAT from VgfC57 -/- mice (Table 2). Although
lipoprotein lipase (LPL) activity is generally regulated at
the post-transcriptional level in adipose tissues (e.g. [53]),
allowing rapid responses to alterations in diet, LPL mRNA
levels correlate with PPAR mRNA levels in epididymal
WAT [54] and increase with PPAR agonist treatment [55],
likely due to a transcriptionally active PPAR response ele-
ment upstream of the LPL gene [56]. Small but significant
decreases in LPL mRNA and PPAR mRNAs were noted in
WAT from VGF knockout mice, while small increases in
both mRNA levels were measured in BAT. Increased LPL
expression in BAT has previously been described in mice
exposed to cold or injected with norepinephrine [57], so
the increased LPL expression we measured in VGFC57
knockout BAT may reflect increased sympathetic pathway
activity. Decreased fat stores could result from continuous
breakdown of triglycerides into fatty acids, which is asso-
ciated with increased fatty acid synthase (FAS) mRNA lev-
els in WAT and higher circulating FFA levels previously
noted in Vgf-/Vgf- mice on a C57Bl6 background [18]. We
further noted increases in cytochrome c oxidase II, PPAR,
PGC1, UCP1, and UCP2 mRNA levels in WAT from VGF
knockout mice. The PGC1 coactivators play essential roles
in BAT differentiation, mitochondrial biogenesis, and
thermogenesis [58], so increased expression of PGC1
could drive alterations in WAT morphology and UCP1
gene expression towards a 'brown fat' phenotype in VgfC57
-/- mice.
Previous studies indicate that induction of UCP1 levels in
the absence of increased adrenergic activity does not nec-
essarily lead to increased UCP1 activity and thermogene-
sis [59,60]. Conversely, the thermogenic capacity of BAT
can be augmented without an associated increase in sym-
pathetic activity, as noted in the Syrian hamster exposed
to a short photoperiod or fed a high-energy diet, where
increased thermogenesis occurs in the absence of changes
in norepinephrine turnover [61-63]. Our metabolic stud-
ies of VGF mutant mice consistently demonstrate
increased O2 consumption irrespective of genetic back-
ground ([21] and this report), and together with the cur-
rent analysis of gene expression, would be most consistent
with increased fatty acid oxidation and decreased lipogen-
esis in adipose tissues, and possibly also thermogenic
activity due to enhanced UCP1 levels in WAT, which
could be associated with increased adrenergic activity. In
BAT, targeted ablation of VGF resulted in increased UCP1
protein levels, increased mitochondrial number, and
increased cristae number per square micron of mitochon-
drial area, suggesting increased sympathetic activity, but
did not increase cold tolerance. Cold intolerance (Figure
6) in VGF mutants could be a result of lack of available
fuel, as in the adlib fed state, these mice have reduced fat
depots and display a fasted phenotype, with little detecta-BMC Physiology 2009, 9:19 http://www.biomedcentral.com/1472-6793/9/19
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VGF is expressed in neural pathways that innervate brown adipose tissue (BAT) Figure 5
VGF is expressed in neural pathways that innervate brown adipose tissue (BAT). In panel A, levels of VGF-derived 
peptides were quantified in BAT from C57Bl6 female mice fed standard chow or a high fat, high carbohydrate diet for 14 days. 
BAT was removed and RIA analysis carried out to quantify C-terminal VGF-derived peptides (NAPP129, TLQP62 and 
AQEE30, but not full length VGF), using polyclonal anti-AQEE30 (VGF588-617) antiserum as previously described [38]. VGF pep-
tide levels in BAT were significantly reduced in mice fed the high-energy diet in comparison to control mice (p < 0.05). Com-
parisons by ANOVA [mean ± SEM; high fat diet (n = 4), standard diet (n = 3)]. In panels B-C, Vgf gene expression was 
visualized in neural pathways that innervate tissues including BAT using a lacZ reporter gene that was knocked into the mouse 
Vgf locus in VGFR mice (see Methods). In panel B, -galactosidase expression (blue staining) in the dorsal root ganglia (white 
arrows) and intercostal nerve (black arrow) is seen in a whole mount preparation from a heterozygous VgfR +/- mouse. A dor-
sal root ganglion section is shown at higher magnification in panel C (scale bar is 100 m in length).BMC Physiology 2009, 9:19 http://www.biomedcentral.com/1472-6793/9/19
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ble liver glycogen, low circulating glucose levels, increased
circulating FFA, elevated hypothalamic NPY and AGRP
mRNA levels, and decreased hypothalamic POMC mRNA
levels [17,18,21]. Alternatively, sympathetic outflow to
various adipose depots could differ, as has been demon-
strated for specific WAT pads during prolonged fasting
and following leptin administration [64,65].
Neonatal monosodium glutamate (MSG) blocks the
development of the lean phenotype in VGFM knockout
mice [17], suggesting that increased SNS activity is associ-
ated with increased fat oxidation and energy expenditure
in homozygous Vgf-/Vgf-  mice. Neonatal guanethidine
treatment, which creates a generalized chemical sym-
pathectomy, also blocked the development of the lean
phenotype in VGFC57 knockout mice, and increased circu-
lating glucose levels (see Additional file 2: Supplemental
Figure 2), but was not sufficiently well-tolerated by VGF
knockout mice to carry out a complete analysis of its
effects. These experiments are consistent with the real-
time PCR data, and a role for increased sympathetic path-
way activity in mice that lack VGF. Although we were una-
ble to study the developing SNS in Vgf-/Vgf- P0 newborn
pups due to insufficient numbers, we did note that tyro-
sine hydroxylase (TH) immunostaining in the SNS of
VgfC57 +/- pups was significantly more robust than VgfC57
+/+ pups, consistent with a possible increase in SNS cate-
cholamine turnover (E. Watson and S. Salton, unpub-
lished data) [66]. Increased sympathetic tone in the
absence of changes in BAT UCP1 gene expression was
noted in lean, hypermetabolic M3 muscarinic acetylcho-
line receptor knockout mice [67], which are very similar
to VGF mutant mice in phenotype, and also largely resist-
ant to high fat diet-induced, gold-thio-glucose-induced
and genetically (ob/ob)-induced obesity, hyperphagia,
hyperinsulinemia, and hyperglycemia [17,18,21,67].
Both cold exposure and overeating increase sympathetic
drive to BAT to stimulate thermogenesis [68-70]. Are the
sympathetic pathways that control increased energy
expenditure and decreased fat storage regulated by inde-
pendent CNS circuits? Adipose-synthesized leptin con-
trols energy balance in part via activation of the SNS [71],
regulating body weight and temperature [72-74]; chemi-
cal sympathectomy with guanethidine blocks this leptin
effect, preventing diet-induced thermogenesis [75]. Leptin
regulates functionally divergent hypothalamic MC4R-
containing pathways to control food intake and energy
expenditure [76]. MC4R mRNA has also been localized in
sympathetic nervous system outflow neurons that inner-
VGF-deficient mice have increased sensitivity to cold exposure Figure 6
VGF-deficient mice have increased sensitivity to cold exposure. VgfC57 -/- and VgfC57 +/+ mice were placed at 4°C for 2 
hours and allowed adlib access to food and water. Mice were individually housed and rectal temperatures were taken every 30 
minutes. Body temperatures that are marked with an asterix from mutant (n = 2) and wild-type mice (n = 5) are significantly 
different from each other (ANOVA; p < 0.05; mean ± SEM).BMC Physiology 2009, 9:19 http://www.biomedcentral.com/1472-6793/9/19
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vate WAT [2]. How the CNS and sympathetic outflow cir-
cuits coordinately regulate lipid mobilization in WAT and
thermogenesis in BAT in response to cold stress and/or
diet is not fully understood, but retrograde tract tracing
with pseudorabies virus suggests that MC4R-expressing
cells in the hypothalamic PVN are positioned to increase
sympathetic drive to both WAT and BAT [2]. It is likely,
however, that both melanocortin and melanocortin-inde-
pendent pathways are involved, as MC4R-deficient mice
are still able to maintain normal body temperature and
thermo-regulate during extended cold exposure [77], but
are apparently unable to up-regulate UCP1 in BAT in
response to short term cold stress or a high fat diet [3].
VGF ablation blocks obesity, hyperglycemia and hyperin-
sulinemia in MC4R-deficient mice [18], so this protein
may function in these outflow pathways to regulate sym-
pathetic nervous system activity and lipid storage.
Adaptive thermogenesis is mediated primarily via beta-
adrenergic receptors, and genetic association studies have
revealed that the genes encoding these receptors include a
large number of coding and non-coding polymorphisms,
which have clear functional consequences but less clear
contributions to the pathogenesis of obesity, diabetes and
hypertension [78]. Mice that lack 1, 2 and 3 adrenergic
receptors ('beta-less' mice) are obese, primarily the result
of defective SNS-dependent activation of diet-induced
thermogenesis because lipolytic responses to fasting were
not altered [79,80]. Siberian hamsters have an increase in
sympathetic drive during short day exposure, which
reduces fat mass [81,82]. This increase in SNS activity cor-
relates with an increase in 3 receptor mRNA levels in adi-
pose tissues [82], and interestingly, we noted an increase
in 3 receptor mRNA levels in VGF knockout BAT but not
WAT, and increased 2 receptor mRNA levels in WAT, per-
haps correlating with increased SNS activity [79]. Recent
studies indicate that norepinephrine can induce lipolysis
in WAT in beta-less mice [83], suggesting a beta-adrenore-
ceptor independent pathway, and moreover, in the
absence of norepinephrine or epinephrine, dopamine-
beta-hydroxylase (DBH) knockout mice are not predis-
posed to obesity, as are beta-less mice, and maintain glu-
cose tolerance [84]. The contribution of beta-
adrenoreceptors and SNS activity to fat mass is therefore
complicated, and notably, leptin-induced decreases in fat
mass are not consistently accompanied by increases in
norepinephrine (NE) turnover, a measure of SNS activity
[65]. Further studies are needed to investigate whether
increased HSL gene expression and lipolysis are associated
with increased NE turnover in specific fat depots from
VGF mutant mice.
Of note, the neuropeptides -MSH and NPY have been
demonstrated to increase and decrease lipolysis, respec-
tively, in fully differentiated 3T3-L1 adipocytes [42], so by
analogy, direct effects of VGF peptides on adipocytes are
also possible, particularly in light of the expression of VGF
in BAT (Figure 5) and in the sympathetic nervous system
[85,86]. We quantified AQEE immunoreactive peptides
by RIA in BAT, and noted that levels decrease in response
to a high fat diet (HFD). Parallel studies with larger
cohorts of C57Bl6 mice have revealed that C57Bl6 mice
consuming a HFD compared to a chow diet generally
increase their energy intake (food consumption in grams
is similar) [87], and after 2 weeks, body weight has not
changed [87], or has increased by ~10% ([88]; J. Mastaitis
and C.V. Mobbs, personal communication and [89]). This
alteration in energy balance is sufficient to trigger com-
pensatory changes in gene expression in liver [87], includ-
ing increased expression of genes involved in fatty acid
oxidation. Our data would suggest that VGF C-terminal
peptide TLQP62, hypothesized to decrease sympathetic
outflow pathway activity to adipose tissues [17,18], is
present in BAT and levels decrease as part of the compen-
satory response to increased energy intake.
Recent experiments have found that 14-day intracerebrov-
entricular (icv) administration of the C-terminal VGF-
derived peptide TLQP21 (VGF residues 556-576)
increases energy expenditure and prevents diet-induced
obesity in mice [90], and decreases food intake and body
weight in hamsters [91]. Analysis of TLQP21-treated mice
revealed a phenotype with numerous additional similari-
ties to VGF knockout mice including increased energy
expenditure, increased WAT 2-adrenergic receptor
mRNA levels, increased WAT UCP1 mRNA levels, normal
locomotor activity, and decreased WAT weight {see
Results and [21]}. However, rather than very similar phe-
notypes, one would anticipate that mice lacking VGF and
those chronically treated with VGF-derived TLQP21 pep-
tide would potentially have opposing metabolic pheno-
types. Because the precise levels of TLQP21 in brain tissue
are not yet known compared to the relatively abundant C-
terminal TLQP62 peptide (VGF residues 556-617), one of
the major VGF-derived peptides detected in neuronal and
endocrine tissues [38,92,93], and different C-terminal
peptides derived from TLQP62 have opposing effects on
energy balance [94], several alternative mechanisms of
action are possible: (1) TLQP21 and TLQP62 could each
activate its own receptor with the overall biological effect
dependent on the concentration of each peptide and the
distribution and affinity of putative receptors, (2) TLQP21
could inhibit actions of full length VGF or longer VGF-
derived C-terminal peptides, including TLQP62 and
NAPP129, which all contain the TLQP21 sequence, and/
or (3) chronic TLQP21 treatment could lead to down-reg-
ulation of VGF receptor(s) and signaling. Consistent with
mechanism 2, we have recently noted that TLQP21, but
not a scrambled peptide, blocks TLQP62-induced electri-
cal potentiation in hippocampal slices [95]. In addition,BMC Physiology 2009, 9:19 http://www.biomedcentral.com/1472-6793/9/19
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Severini et al. [96] have recently described a role for
TLQP21 in cerebellar granule neuron survival and cellular
signaling, and in the regulation of gastric motor function
[97]. Taken together, these data indicate that specific VGF-
derived peptides are biologically active, and may signal
through independent or shared cell surface receptor(s) to
regulate autonomic homeostasis and peripheral adipos-
ity.
Conclusion
Study of two independent VGF knockout mouse lines
indicates that Vgf gene products regulate fat storage and
energy expenditure through a mechanism that is inde-
pendent of an effect on locomotor activity. Histological
and electron microscopic analysis, coupled with real-time
PCR and western analysis, demonstrate physiological and
morphological changes in VGF germline knockout mice
that are consistent with decreased fat storage, decreased
adipocyte area, increased lipolysis, and decreased lipogen-
esis in WAT, and increased fatty acid oxidation, increased
UCP1 and UCP2 protein levels, and increased mitochon-
drial number and cristae density in BAT. Identification of
VGF in BAT, together with these data, supports the
hypothesis that VGF and/or VGF-derived peptides modu-
late sympathetic outflow pathways that regulate adiposity
and energy expenditure.
Methods
Mouse Strains and Diets
Previously described mice with a targeted deletion of the
Vgf gene on a mixed C57Bl/6 and 129/SVJ background
(designated VGFM or VgfM -/-) [21], were repetitively back-
crossed 10 generations onto wild type C57Bl/6 mice (des-
ignated VGFC57 or VgfC57 -/-), and heterozygous Vgf+/Vgf-
mice on a homogenous C57Bl/6 background were mated
to generate wild type, heterozygous, and homozygous
VGF-deficient mice. A second VGF-deficient line was gen-
erated by Regeneron Pharmaceuticals Inc. as previously
described [25] using F1H4 ES cells (a 129B6/F1-derived
cell line) and a BAC-based targeting vector with deletion
of the entire Vgf coding sequence and insertion of an in
frame lacZ reporter gene and neomycin-selection cassette;
chimeric mice resulted from the injection of two inde-
pendent  Vgf-/Vgf-  embryonic stem cell clones into
C57BL6/J blastocysts. Male chimeras were mated with
C57BL6/J females to produce F1 breeders and experi-
ments were performed on N2F1 mice (>83% C57Bl6
background; designated VGFR or VgfR -/-) from two sepa-
rate clones with similar results.
Mice were housed at room temperature in a 12 h light, 12
h dark cycle, with chow and water available adlib unless
otherwise specified. Mice fed standard chow received a
4.5% fat, 55% carbohydrate, 20% protein, 4.7% fiber diet
(Purina PicoLab Rodent Diet 20-5053; 4 Kcal/gm; Purina.
St. Louis, MO). For high fat diet studies, mice received a
high fat (33.5-35.5%) and high simple carbohydrate (34-
35.5%) diet that also contained 20% protein and 0.1%
fiber (Bio-Serv F2685; 5.4 kcal/g). All animal studies were
conducted in accordance with the Guide for Care and Use
of Experimental Animals, using protocols approved by
Institutional Animal Care and Use Committees at Mount
Sinai School of Medicine or Regeneron Pharmaceuticals
Inc.
Tissue Preparation and Immunohistochemistry
Mice were sacrificed and white and brown adipose tissues
removed, fixed in formalin and embedded in paraffin.
Sections (5 m) were stained with hemotoxylin and
eosin. Transcardial perfusions were performed with 4%
paraformaldehyde in PBS after washing in saline solution.
After perfusion brown adipose tissue was dissected and
fixed overnight in the same fixative and then embedded in
paraffin for immunohistochemistry. Polyclonal rabbit
antibodies were raised against a VGF (amino acids 8-349)-
trpE fusion protein [98]. Dewaxed sections (10 m) were
processed through the following steps for antigen
retrieval: (1) treated with 0.3% hydrogen peroxide in
methanol for 20 minutes; (2) microwaved for 20 minutes
in 10 mM citric acid buffer to retrieve antigens; (3) incu-
bated for 48 hours at 4°C in PBS that contained 0.3% Tri-
ton X100, 3% normal goat, 3% horse serum, and anti-
VGF or anti-tyrosine hydroxylase (Chemicon Interna-
tional, Temecula, CA) antibody (1:50); (4) incubated for
1 hour in biotinylated secondary antibody, goat anti-rab-
bit IgG (1:200). Staining was performed using an avi-
din:biotyinylated enzyme complex (vector ABC kit, Vector
laboratories, Burlingame, CA) with diaminobenzidine as
a substrate. For immunofluorescence, polyclonal rabbit
anti-VGF (1:1000) was used to stain BAT. Dewaxed sec-
tions (10 m) were subjected to an antigen retrieval step,
were incubated overnight at 4°C in PBS that contained
0.3% Triton X100, 3% normal goat, 3% horse serum, and
VGF antibody (1:50), and lastly with Texas red goat anti-
rabbit 1:250 for 1 hour. Staining was visualized using a
Zeiss Axiophot microscope.
Morphometry
Isolated BAT and WAT were immersed and fixed in forma-
lin, embedded in paraffin, sectioned, and stained with
H&E. Slides were analyzed using Zeiss Axiophot micro-
scope and images captured with a SPOT digital camera.
Calculation of mean cell size, lipid area, and cell size dis-
tribution was performed using MetaMorph Imaging Soft-
ware (Molecular Devices, Downingtown, PA). For image
analysis, 6 images per group were randomly selected to
measure the mean cell size and size distribution in WAT.
Groups consisted on 2 mice of each genotype [wild type
(Vgf+/Vgf+), heterozygous knockout (Vgf+/Vgf-), and
homozygous knockout (Vgf-/Vgf-)], and images wereBMC Physiology 2009, 9:19 http://www.biomedcentral.com/1472-6793/9/19
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taken with 20× and 10× objectives for BAT and WAT,
respectively. Mean cell size and size distribution were
determined from 390 adipocytes in WAT. As it was diffi-
cult to outline the cells in BAT because of the accumula-
tion of lipid in the cytoplasm, lipid area in BAT was
quantified using MetaMorph Imaging Software.
Electron Microscopy
For electron microscopic examination, BAT samples were
placed in ice-cold fixative buffer (3% gluteraldehyde in
0.2 M sodium cacodylate buffer pH 7.3) for 2 h. Speci-
mens were washed in 0.2 M sodium cacodylate buffer pH
7.3 for 10 min, postfixed in 1% osmium tetroxide in 0.2
M sodium cacodylate buffer for 1 h, washed and dehy-
drated in graded ethyl alcohol steps, and embedded in
pure EPON A&B mixture with DMP-30. Ultrathin sections
for electron microscopy were examined using a Hitachi
H7650 instrument linked to an SIA digital camera (Scien-
tific Instruments and Applications, Duluth, GA) control-
led by Maxim CCD software. Electron micrographs were
obtained at 20,000× magnification, and mitochondrial
analysis was carried out using MetaMorph Imaging Soft-
ware. Six images per group [2 mice of each genotype: wild
type (Vgf+/Vgf+) and homozygous knockout (Vgf-/Vgf-)]
were randomly chosen, and the number and the area of
mitochondria/m2 were measured. The mean mitochon-
drial area/m2 was determined from 316 mitochondria in
BAT. The cristea number was calculated from 40 mito-
chondria for each group (2 images/group).
Western Blot Analysis
BAT and epididymal WAT from wild type (Vgf+/Vgf+), het-
erozygous knockout (Vgf+/Vgf-), and homozygous knock-
out (Vgf-/Vgf-) (n = 5 mice for each group) were
homogenized in ice cold lysis buffer [50 mM Tris-HCl
(pH 8) 150 mM NaCl, 0.02% sodium azide, 0.1% SDS,
0.5% deoxycholate and 1% NP40] supplemented with
protease and phosphatase inhibitor cocktails (Roche
Diagnostics, Mannheim, Germany; Thermo Scientific,
Waltham, MA). Lysates were cleared by centrifugation
(14,000 rpm, 10 min at 4°C), and the protein concentra-
tion of the supernatant determined by the BCA protein
method (Thermo Scientific). Protein samples (25 g)
were separated by SDS-PAGE and transferred to nitrocel-
lulose membranes (Millipore, Bedford, MA). Membranes
were blocked with 5% (W/V) BSA in phosphate-buffered
saline, and were probed with rabbit polyconal anti-UCP1
[1:1000 (v/v)] (Calbiochem, San Diego CA), rabbit poly-
conal anti-UCP2 [1:1000 (v/v)] (Calbiochem), or mouse
monoclonal anti-GAPDH [1:1000 (v/v)] (Cell Signaling
Technology, Danvers, MA), at 4°C overnight. After 3
washes in PBS-T (0.1% Tween in PBS) membranes were
incubated for 1 hour with HRP-conjugated secondary
antibody [1:10,000 (v/v) in PBS-T] (GE Healthcare, Pis-
cataway, NJ) containing 5% non-fat dry milk. After 3
washes in PBS-T bound antibodies were detected using
ECL (Thermo Scientific) and exposure to HyBlot CL (Den-
ville Scientific, Metuchen, NJ). Densitometric quantifica-
tion was performed using NIH ImageJ.
-galactosidase Histology
For -galactosidase staining, mice were deeply anesthe-
tized (240 mg/kg ketamine, 48 mg/kg xylazine i.m.) and
exsanguinated with ice-cold heparinized saline. Tissues
were fixed by transcardial perfusion of 2% paraformalde-
hyde in 0.1 M phosphate buffer, postfixed for 2 hr, and
then washed in several changes of phosphate-buffered
saline. Whole mount staining was then carried out essen-
tially as previously described [99,100], preparations were
examined, and then cryoprotected for a least 24 hr in two
changes of buffered 30% sucrose at 4°C with agitation
before sectioning.
Radioimmunoassay
Tissues were sonicated and extracted in 0.1 M acetic acid
for 6-7 min at 70°C [101]. Homogenates were subjected
to centrifugation (14,000 × g for 30 min, 4°C), and the
supernatants were dried using a Speed Vac concentrator
(Sorvall) and stored at -80°C. Samples were resuspended
in 0.1 M NaHPO4, 0.1% TritonX-100, pH 7.2 and sub-
jected to RIA. Rabbit polyclonal antiserum directed
against the VGF-derived C-terminal AQEE30 peptide was
utilized, and RIAs carried out as previously described [38].
Under these acid extraction conditions, the RIA directed
against the C-terminal AQEE30 peptide would also be
expected to cross-react with N-terminally extended pep-
tides TLQP62 and NAPP129 in these tissue extracts.
RNA isolation and RT-PCR
Mice were sacrificed, and brown and white (epididymal
fat pads) adipose tissues were removed, flash frozen on
dry ice, and stored at -80°C until use. Fat pads were
homogenized in Trizol and RNA was extracted according
to the manufacturer's instructions (Invitrogen Corpora-
tion, Carlsbad, CA). Total RNA (5 g) was reverse tran-
scribed in a 20 l reaction using Superscript II enzyme
(Invitrogen Corporation, Carlsbad, CA), and single
stranded cDNA was diluted 1:50 for RT-PCR. Using Syber
Green Master Mix (Applied Biosystems, Foster City, CA),
amplification was performed in ABI Prism 8500 system
for 40 cycles in quadruplicate. SDS 2.1 software was used
for analyzing cycle threshold (Ct) values, and expression
of the housekeeping gene beta actin was used to normal-
ize levels according to the following formula: Ct = (Ct
geneX VGFko - Ct actin VGFko) - (Ct geneX wild type - Ct
actin wild type). Fold difference in mRNA levels between
Vgf-/Vgf- and Vgf+/Vgf+ = 2Ct. Forward and reverse prim-
ers were designed based on published studies and on
database analysis as follows: acetyl-CoA carboxylase
(ACC), 5'-CAGATCCAGGCCATGTTGAGACG and 3'-TCGBMC Physiology 2009, 9:19 http://www.biomedcentral.com/1472-6793/9/19
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CTGGGTGGGTGAGATGTG; beta-1-adrenergic receptor
(1AR), 5'-CGGCTGCAGACGCTCACCAA and 3'-CGCCA
CCAGTGCATGAGGAT; beta-2-adrenergic receptor
(2AR), 5'-GCTGCAGAAGATAGACAAAT and 3'-GGGAT
CCTCACACAGCAGTT; beta-3-adrenergic receptor
(3AR), 5'-CTGCTAGCATCGAGACCTT and 3'-CGAG-
CATAGACGAAGAGCAT; carnitine palmitoyltransferase 1
(CPT1), 5'-ACCACTGGCCGAATGTCACAA and 3'-AGCG
CGTAGCGCATGGTCAT; cytochrome C oxidase II (COX
II), 5'-CGATTCCAACTTGGTCTACAA and 3'-GGAACCAT
TTCTAGGACAATG; diacylglycerol acyltranferase (DGAT),
5'-TCCGCCTCTGGGCATTC and 3'-GAATCGGCCCAC
AATCCA; fatty acid synthase (FAS), 5'-TGCTCCCAGCT-
GCAGGC and 3'-GCCCGGTAGCTCTGGGTGTA; glucose-
4-transporter (GLUT4), 5'-CTCAGCAGCGAGTGACT-
GGGAC and 3'-CCCTGAGTAGGCGCCAATGAGG; glyc-
erol-3-phosphate acyltransferase (GPAT), 5'-CAGCTCT
GCTGCCATCTTTG and 3'-TGCAGCTTCTGCAGG-
TACTCA; hormone sensitive lipase (HSL), 5'-GAAAAACA
GCCTGTCGGACCA and 3'-CCAGGGCGATCTGCAGGT;
insulin receptor (IR), 5'-GTAGCCTGATCATCAACATCCG
and 3'-CCTGCCCATCAAACTCTGTCAC; insulin receptor
substrate 1 (IRS1), 5'-CCTCTCCAACGCCAGAAGCTGCC
and 3'-ATGGCGAGCCCTCCGGATACCG; insulin recep-
tor substrate 2 (IRS2), 5'-GGATAATGGTGACTATACCGA
GA and 3'-CTCACATCGATGGCGATATAGTT; lipoprotein
lipase (LPL), 5'-AGGACCCCTGAAGACAC and 3'-GGCAC
CCAACTCTCATA; peroxisome proliferator activated
receptor alpha (PPAR), 5'-TCCCTTGTAGCCTTTTGTCAT
and 3'-AAGCCATTGCCGTACGCGAT; peroxisome prolif-
erator activated receptor gamma (PPAR), 5'-AGGCCGA-
GAAGGAGAAGCTGTTG and 3'-TGGCCACCTCTTTG
CTCTGCTC; PPAR coactivator 1 (PGC-1), 5'-AAAGAAT-
TCGAACTAAGGGATGGCGACTT and 3'-ATAGGATCCG-
GAATATGGTGATCGGGAAC; sterol regulatory element
binding protein 1C (SREBP1C), 5'-GAGGCACTCCCCC
AAAAGAT and 3'-TGATGAGAGGGAGGCCATTT; uncou-
pling protein 1 (UCP1), 5'-GATCCAAGGTGAAGGCC
AGG and 3'-GTTGACAAGCTTTCTGTGG; uncoupling
protein 2 (UCP2), 5'-GTGACCTGCTGCGCTGTGGTACT
and 3'-GATCCAAGGGGAGAGTCA; housekeeping gene
(beta actin), 5'-TGCTGTCCCTGTATGCCTCT and 3'-AGG
TCTTTACGGATGTCACG
Indirect Calorimetry, Body Composition and Serum 
Chemistries
Metabolic measurements were assessed on a regular diet
(at 9-10 weeks of age) and were obtained using an Oxy-
max (Columbus Instruments International Corp.) open
circuit indirect calorimetry system as previously described
[102]. The first 2 h was a period of adaptation for the ani-
mals, and metabolic rate (VO2), RQ (ratio of VCO2/VO2)
and activity (counts) were then evaluated for a 72-h
period. Energy expenditure was calculated as the product
of calorific value of oxygen (calorific value of oxygen =
3.815 + 1.232 RQ) and the volume of O2 consumed and
this was normalized for body weight in kilograms. Two
cohorts of male mice between 2-3 months of age (n = 7-8
mice of each genotype per cohort) were utilized for body
composition, serum chemistry and metabolic cage analy-
sis, carried out as described above and detailed previously
[103].
Data and Statistical Analysis
Data are expressed as mean ± SEM. Comparisons were
performed using t test or repeated-measures analysis of
variance (ANOVA) where appropriate, using the programs
Statview and Prism. P-values less than 0.05 were consid-
ered significant. For metabolic cage analysis, basal meta-
bolic rate (BMR), defined as oxygen consumption during
the light rest period, was determined by comparing VO2
measurements of VGFR knockout and wild-type litterma-
tes by two-tailed t-test. For real-time RT-PCR, assays were
carried out in quadruplicate, and mean cycle threshold
(Ct) values (± SEM) were compared by two-way ANOVA
(p  0.05 was considered significant). These values were
used to calculate fold difference in mRNA levels (2Ct).
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Additional file 1
Supplemental Figure 1. Lipid deposition in multilocular cells of brown 
adipose tissue (BAT) and unilocular cells of white adipose tissue 
(WAT) is reduced in VGFC57 knockout mice. Representative sections of 
interscapular BAT (A-D) and epididymal WAT (E-F) from ad lib-fed 
VgfC57 -/- (A, C and E) and age-matched VgfC57 +/+ (B, D, and F) mice 
were stained with H&E. The interscapular WAT that normally surrounds 
BAT in wild type mice (D) was absent in VGF-deficient mice (A and C). 
Adipocytes in interscapular BAT and epididymal WAT from VgfC57 -/- 
mice (A and E) contain less lipid accumulation than the corresponding 
adipocytes from wild type mice (B and F). Scale bars are 100 m in 
length.
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